The Prostatype® Test System is a new gene test that provides:
- Prognosis of survival
- Decision support for various treatment options
The Prostatype® Test System combines gene expression information with the currently used clinical parameters (PSA, Gleason Score, Tumor Stage, and age). Based on a unique database containing authentic information from 600 historic prostate cancer patients, the Prostatype® Test System provides decision support for patients and doctors when making a treatment decision. This reduces the risk of over- or undertreatment and can postpone repeated biopsies.